Evidence map›Paper›PMID 34465259›Full record

ReviewPharmaceutical biology2021

The beneficial effects of

Sze Wa Chan, Brian Tomlinson, Paul Chan, Christopher Wai Kei Lam

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 55 citations in OpenAlex.

  1. Clinical Evaluation ofNutrients · 2025
    Trial
  2. Article
  3. Article
  4. Metabolites · 2026
    Review
  5. Article
  6. Review
  7. Comparing the Effects ofClinical diabetes : a publication of the American Diabetes Association · 2025
    Article
  8. Unlocking the Potential ofPharmaceutics · 2025
    Review
  9. The Anti-Inflammatory Effect ofInternational journal of molecular sciences · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Triterpenoids fromFrontiers in pharmacology · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Sze Wa ChanSchool of Health Sciences, Caritas Institute of Higher Education, Hong Kong SAR, China.ORCID https://orcid.org/0000-0002-2979-3855
Brian TomlinsonFaculty of Medicine, Macau University of Science & Technology, Macau, China.ORCID https://orcid.org/0000-0001-6717-5444
Paul ChanDivision of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan.ORCID https://orcid.org/0000-0003-4958-5487
Christopher Wai Kei LamFaculty of Medicine, Macau University of Science & Technology, Macau, China.ORCID https://orcid.org/0000-0003-3994-2030
Macau University of Science and Technology · MOSaint Francis University · HKWan Fang Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextVarious herbal medicines are thought to be useful in the management of cardiometabolic disease and its risk factors.

objectiveThis review focuses on the major studies of the whole plant, plant extract, and specific active compounds isolated from

methodsReferences from major databases including PubMed, Web of Science, and Google Scholar were compiled. The search terms used were

resultsA number of

conclusionsThe inconsistent evidence about the potential health benefits of

Indexed as

AnimalsCardiometabolic Risk FactorsCardiovascular DiseasesDrugs, Chinese HerbalHumansHypoglycemic AgentsMetabolic DiseasesReishiDrugs, Chinese HerbalHypoglycemic AgentsAntihypertensiveantioxidantdyslipidaemiahypoglycaemicLingzhiReishi

Identifiers

PMID34465259
PMCPMC8409941
OpenAlexW3197953121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.